PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding ▲ | PubMed ID |
---|---|---|---|---|---|---|---|
CTB-PsaA pentamers
|
GM1
|
Monosialoglycosphingolipids
|
Serum, Saliva, Nasal/bronchial wash samples
|
Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Unknown
|
Sialyl-3-Paragloboside (S-3-PG; α2,3-sialylparagloboside)
|
Monosialoglycosphingolipids
|
Granulocytes
|
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Hemagglutinin (HA)
|
Sialyl-3-Paragloboside (S-3-PG; α2,3-sialylparagloboside)
|
Monosialoglycosphingolipids
|
Various human tissues (leukocytes/erythrocytes/small intestine/stomach/meconium/colon/pancreas)
|
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Unknown
|
GM1
|
Monosialoglycosphingolipids
|
Human brain
|
Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
S-fimbriae
|
unnamed ligand
|
Oligosaccharides
|
Neural cell lines
|
NeuAc(a2-3)Gal(b1-3)GalNAc
|
Binding
|
||
Capsid protein VP1
|
Sialylated oligosaccharides
|
Oligosaccharides
|
Cell surface
|
NeuAc(a2-3)Gal(b1-3)GalNAc
|
Binding
|
||
Unknown
|
unnamed ligand
|
Oligosaccharides
|
Stomach
|
NeuAc(a2-3)Gal(b1-4)GlcNAc
|
Binding
|
||
Unknown
|
Sialylated oligosaccharides
|
Oligosaccharides
|
Erythrocytes
|
NeuAc(a2-3)Gal(b1-3)GalNAc
|
Binding
|
||
K99
|
unnamed ligand
|
Oligosaccharides
|
Intestinal cells
|
NeuAc(a2-3)Gal(b1-4)Glc
|
Binding
|
||
Residues 226 (glutamine) and 228 (glycine)
|
Sialic acid linked to α2,3Galβ1,3GalNAc
|
Oligosaccharides
|
Avian/equine isolates
|
NeuAc(a2-3)Gal(b1-3)GalNAc
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01